Results 121 to 130 of about 24,972 (163)

Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures. [PDF]

Saudi Pharm J
Almudimeegh S.
europepmc   +1 more source

Subcutaneous Incobotulinumtoxin-A for Refractory Central Post-Stroke Neuropathic Pain: A Report of Two Cases. [PDF]

Toxins (Basel)
Carda S, Grana E.
europepmc   +1 more source

Analysis of the epidemiological characteristics of foodborne botulism in Xinjiang, China from 2016 to 2024. [PDF]

BMC Infect Dis
Danai A, Huang J, Su J, Meng W, Lin Y, Yuan Y, Ma X.   +6 more
europepmc   +1 more source

Risk of Cervical Spine Complications in Individuals with Cervical Dystonia Treated with Botulinum Toxin Therapy. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Senthil S, Kumar S, Shukla AW.
europepmc   +1 more source

Botulinum Toxin Treatment of Stiff Person Syndrome-A Critical Review and Update. [PDF]

Toxins (Basel)
Tohidian AG, Comtesse SM, Etemadmoghadam S, Jabbari B.   +3 more
europepmc   +1 more source

Dexamethasone Admixture for Hypersensitivity Prevention in Botulinum Toxin Type A Treatment: A Case Report. [PDF]

J Cosmet Dermatol
Jia X, Liang Y, Chen Q, Hu J.
europepmc   +1 more source

Tetracaine Eye Drops as a Preemptive Topical Skin Anesthesia for Botulinum Toxin Type A Injections in Blepharospasm Patients: A Randomized Controlled Trial. [PDF]

Clin Ophthalmol
Pinitpanich N, Hirunwiwatkul P, Ongprakobkul C, Tulvatana W.   +3 more
europepmc   +1 more source

Mapping the UK Aesthetic Medicine Industry: Practitioner Profiles, Pricing, and Socioeconomic Gradients in Botulinum Toxin Practice. [PDF]

Aesthet Surg J Open Forum
Zargaran A, Zargaran D, Khademi Mansour HR, Turan L, Bocciardi G, Liu Y, Golash A, Daneshi K, Pirayesh A, Woollard A, Mosahebi A.   +10 more
europepmc   +1 more source

Topical imiquimod in the management of botulinum toxin-induced upper eyelid ptosis: A case series. [PDF]

JAAD Case Rep
Abou Tayeh S, Merhi R, Khachan MJ, Obeid C, Ayoub N.   +4 more
europepmc   +1 more source